ParkinsonFranceV1, PubMed, Corpus, bibRecord, 000346

Botulinum Toxin-A for treatment of Pisa syndrome: A new target muscle.

Identifieur interne : 000346 ( PubMed/Corpus ); précédent : 000345; suivant : 000347

Botulinum Toxin-A for treatment of Pisa syndrome: A new target muscle.

Auteurs : Arnaud Dupeyron ; Emilie Viollet ; Flavia Coroian ; Corinne Gagnard ; Dimitri Renard ; Giovanni Castelnovo

Source :

Parkinsonism & related disorders [ 1873-5126 ] ; 2015.

RBID : pubmed:25899457

English descriptors

KwdEn :
- Biomechanical Phenomena (drug effects), Botulinum Toxins, Type A (administration & dosage), Botulinum Toxins, Type A (therapeutic use), Diagnosis, Differential, Dystonia (diagnosis), Dystonia (drug therapy), Dystonia (etiology), Humans, Parkinson Disease (complications), Parkinson Disease (physiopathology), Posture, Range of Motion, Articular (drug effects), Syndrome.
MESH :
- chemical , administration & dosage : Botulinum Toxins, Type A.
- complications : Parkinson Disease.
- diagnosis : Dystonia.
- drug effects : Biomechanical Phenomena, Range of Motion, Articular.
- drug therapy : Dystonia.
- etiology : Dystonia.
- physiopathology : Parkinson Disease.
- chemical , therapeutic use : Botulinum Toxins, Type A.
- Diagnosis, Differential, Humans, Posture, Syndrome.

DOI: 10.1016/j.parkreldis.2015.03.027
PubMed: 25899457

Links to Exploration step

pubmed:25899457

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Botulinum Toxin-A for treatment of Pisa syndrome: A new target muscle.</title>
<author><name sortKey="Dupeyron, Arnaud" sort="Dupeyron, Arnaud" uniqKey="Dupeyron A" first="Arnaud" last="Dupeyron">Arnaud Dupeyron</name>
<affiliation><nlm:affiliation>M2H Laboratory, Euromov, Montpellier 1 University, Montpellier, France; Physical Medicine & Rehabilitation Department, Caremeau Hospital, Montpellier 1 University, Nîmes, France. Electronic address: arnaud.dupeyron@univ-montp1.fr.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Viollet, Emilie" sort="Viollet, Emilie" uniqKey="Viollet E" first="Emilie" last="Viollet">Emilie Viollet</name>
<affiliation><nlm:affiliation>Physical Medicine & Rehabilitation Department, Caremeau Hospital, Montpellier 1 University, Nîmes, France.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Coroian, Flavia" sort="Coroian, Flavia" uniqKey="Coroian F" first="Flavia" last="Coroian">Flavia Coroian</name>
<affiliation><nlm:affiliation>Physical Medicine & Rehabilitation Department, Lapeyronie Hospital, Montpellier 1 University, Montpellier, France.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Gagnard, Corinne" sort="Gagnard, Corinne" uniqKey="Gagnard C" first="Corinne" last="Gagnard">Corinne Gagnard</name>
<affiliation><nlm:affiliation>Department of Electrophysiology, Caremeau Hospital, Montpellier 1 University, Nîmes, France.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Renard, Dimitri" sort="Renard, Dimitri" uniqKey="Renard D" first="Dimitri" last="Renard">Dimitri Renard</name>
<affiliation><nlm:affiliation>Department of Neurology, Caremeau Hospital, Montpellier 1 University, Nîmes, France.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Castelnovo, Giovanni" sort="Castelnovo, Giovanni" uniqKey="Castelnovo G" first="Giovanni" last="Castelnovo">Giovanni Castelnovo</name>
<affiliation><nlm:affiliation>Department of Neurology, Caremeau Hospital, Montpellier 1 University, Nîmes, France.</nlm:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2015">2015</date>
<idno type="RBID">pubmed:25899457</idno>
<idno type="pmid">25899457</idno>
<idno type="doi">10.1016/j.parkreldis.2015.03.027</idno>
<idno type="wicri:Area/PubMed/Corpus">000346</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000346</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Botulinum Toxin-A for treatment of Pisa syndrome: A new target muscle.</title>
<author><name sortKey="Dupeyron, Arnaud" sort="Dupeyron, Arnaud" uniqKey="Dupeyron A" first="Arnaud" last="Dupeyron">Arnaud Dupeyron</name>
<affiliation><nlm:affiliation>M2H Laboratory, Euromov, Montpellier 1 University, Montpellier, France; Physical Medicine & Rehabilitation Department, Caremeau Hospital, Montpellier 1 University, Nîmes, France. Electronic address: arnaud.dupeyron@univ-montp1.fr.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Viollet, Emilie" sort="Viollet, Emilie" uniqKey="Viollet E" first="Emilie" last="Viollet">Emilie Viollet</name>
<affiliation><nlm:affiliation>Physical Medicine & Rehabilitation Department, Caremeau Hospital, Montpellier 1 University, Nîmes, France.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Coroian, Flavia" sort="Coroian, Flavia" uniqKey="Coroian F" first="Flavia" last="Coroian">Flavia Coroian</name>
<affiliation><nlm:affiliation>Physical Medicine & Rehabilitation Department, Lapeyronie Hospital, Montpellier 1 University, Montpellier, France.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Gagnard, Corinne" sort="Gagnard, Corinne" uniqKey="Gagnard C" first="Corinne" last="Gagnard">Corinne Gagnard</name>
<affiliation><nlm:affiliation>Department of Electrophysiology, Caremeau Hospital, Montpellier 1 University, Nîmes, France.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Renard, Dimitri" sort="Renard, Dimitri" uniqKey="Renard D" first="Dimitri" last="Renard">Dimitri Renard</name>
<affiliation><nlm:affiliation>Department of Neurology, Caremeau Hospital, Montpellier 1 University, Nîmes, France.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Castelnovo, Giovanni" sort="Castelnovo, Giovanni" uniqKey="Castelnovo G" first="Giovanni" last="Castelnovo">Giovanni Castelnovo</name>
<affiliation><nlm:affiliation>Department of Neurology, Caremeau Hospital, Montpellier 1 University, Nîmes, France.</nlm:affiliation>
</affiliation>
</author>
</analytic>
<series><title level="j">Parkinsonism & related disorders</title>
<idno type="eISSN">1873-5126</idno>
<imprint><date when="2015" type="published">2015</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Biomechanical Phenomena (drug effects)</term>
<term>Botulinum Toxins, Type A (administration & dosage)</term>
<term>Botulinum Toxins, Type A (therapeutic use)</term>
<term>Diagnosis, Differential</term>
<term>Dystonia (diagnosis)</term>
<term>Dystonia (drug therapy)</term>
<term>Dystonia (etiology)</term>
<term>Humans</term>
<term>Parkinson Disease (complications)</term>
<term>Parkinson Disease (physiopathology)</term>
<term>Posture</term>
<term>Range of Motion, Articular (drug effects)</term>
<term>Syndrome</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Botulinum Toxins, Type A</term>
</keywords>
<keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Dystonia</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Biomechanical Phenomena</term>
<term>Range of Motion, Articular</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Dystonia</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Dystonia</term>
</keywords>
<keywords scheme="MESH" qualifier="physiopathology" xml:lang="en"><term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Botulinum Toxins, Type A</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Diagnosis, Differential</term>
<term>Humans</term>
<term>Posture</term>
<term>Syndrome</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">25899457</PMID>
<DateCreated><Year>2015</Year>
<Month>05</Month>
<Day>22</Day>
</DateCreated>
<DateCompleted><Year>2016</Year>
<Month>05</Month>
<Day>02</Day>
</DateCompleted>
<DateRevised><Year>2015</Year>
<Month>05</Month>
<Day>22</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-5126</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>21</Volume>
<Issue>6</Issue>
<PubDate><Year>2015</Year>
<Month>Jun</Month>
</PubDate>
</JournalIssue>
<Title>Parkinsonism & related disorders</Title>
<ISOAbbreviation>Parkinsonism Relat. Disord.</ISOAbbreviation>
</Journal>
<ArticleTitle>Botulinum Toxin-A for treatment of Pisa syndrome: A new target muscle.</ArticleTitle>
<Pagination><MedlinePgn>669-70</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.parkreldis.2015.03.027</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S1353-8020(15)00130-3</ELocationID>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Dupeyron</LastName>
<ForeName>Arnaud</ForeName>
<Initials>A</Initials>
<AffiliationInfo><Affiliation>M2H Laboratory, Euromov, Montpellier 1 University, Montpellier, France; Physical Medicine & Rehabilitation Department, Caremeau Hospital, Montpellier 1 University, Nîmes, France. Electronic address: arnaud.dupeyron@univ-montp1.fr.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Viollet</LastName>
<ForeName>Emilie</ForeName>
<Initials>E</Initials>
<AffiliationInfo><Affiliation>Physical Medicine & Rehabilitation Department, Caremeau Hospital, Montpellier 1 University, Nîmes, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Coroian</LastName>
<ForeName>Flavia</ForeName>
<Initials>F</Initials>
<AffiliationInfo><Affiliation>Physical Medicine & Rehabilitation Department, Lapeyronie Hospital, Montpellier 1 University, Montpellier, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Gagnard</LastName>
<ForeName>Corinne</ForeName>
<Initials>C</Initials>
<AffiliationInfo><Affiliation>Department of Electrophysiology, Caremeau Hospital, Montpellier 1 University, Nîmes, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Renard</LastName>
<ForeName>Dimitri</ForeName>
<Initials>D</Initials>
<AffiliationInfo><Affiliation>Department of Neurology, Caremeau Hospital, Montpellier 1 University, Nîmes, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Castelnovo</LastName>
<ForeName>Giovanni</ForeName>
<Initials>G</Initials>
<AffiliationInfo><Affiliation>Department of Neurology, Caremeau Hospital, Montpellier 1 University, Nîmes, France.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016422">Letter</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2015</Year>
<Month>04</Month>
<Day>13</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>England</Country>
<MedlineTA>Parkinsonism Relat Disord</MedlineTA>
<NlmUniqueID>9513583</NlmUniqueID>
<ISSNLinking>1353-8020</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>EC 3.4.24.69</RegistryNumber>
<NameOfSubstance UI="D019274">Botulinum Toxins, Type A</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D001696" MajorTopicYN="N">Biomechanical Phenomena</DescriptorName>
<QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D019274" MajorTopicYN="N">Botulinum Toxins, Type A</DescriptorName>
<QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName>
<QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D003937" MajorTopicYN="N">Diagnosis, Differential</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D004421" MajorTopicYN="N">Dystonia</DescriptorName>
<QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
<QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
<QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D010300" MajorTopicYN="N">Parkinson Disease</DescriptorName>
<QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName>
<QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011187" MajorTopicYN="Y">Posture</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D016059" MajorTopicYN="N">Range of Motion, Articular</DescriptorName>
<QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D013577" MajorTopicYN="N">Syndrome</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Botulinum toxin</Keyword>
<Keyword MajorTopicYN="N">Parkinson disease</Keyword>
<Keyword MajorTopicYN="N">Pisa syndrome</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year>
<Month>01</Month>
<Day>02</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised"><Year>2015</Year>
<Month>03</Month>
<Day>28</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2015</Year>
<Month>03</Month>
<Day>31</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2015</Year>
<Month>4</Month>
<Day>23</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2015</Year>
<Month>4</Month>
<Day>23</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2016</Year>
<Month>5</Month>
<Day>3</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">25899457</ArticleId>
<ArticleId IdType="pii">S1353-8020(15)00130-3</ArticleId>
<ArticleId IdType="doi">10.1016/j.parkreldis.2015.03.027</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/PubMed/Corpus

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000346 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 000346 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    PubMed
   |étape=   Corpus
   |type=    RBID
   |clé=     pubmed:25899457
   |texte=   Botulinum Toxin-A for treatment of Pisa syndrome: A new target muscle.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i   -Sk "pubmed:25899457" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd   \
       | NlmPubMed2Wicri -a ParkinsonFranceV1

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024

	La maladie de Parkinson en France (serveur d'exploration)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

La maladie de Parkinson en France (serveur d'exploration)

Botulinum Toxin-A for treatment of Pisa syndrome: A new target muscle.

Botulinum Toxin-A for treatment of Pisa syndrome: A new target muscle.

Source :

English descriptors

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki